TD Cowen lowered the firm’s price target on DexCom (DXCM) to $84 from $100 and keeps a Buy rating on the shares. The firmsaid they possted a solid Q3 and they see many drivers kicking in despite management comments on 2026 growth.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXCM: